Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Scott Maslan currently holds 112,780 shares of CYTOMEDIX INC (GTF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Scott Maslan has been a net buyer of GTF stock. They have purchased $43.9K and sold $0 worth of shares.
Andrew Scott Maslan's most recent insider trade was on Aug 7, 2012, when they sold 10,000 shares at $1.00 per share.
Andrew Scott Maslan serves as Executive at CYTOMEDIX INC (GTF). They have executed 24 insider transactions totaling $43.9K over their tenure at the company.
Andrew Scott Maslan holds the position of Executive at CYTOMEDIX INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Andrew Scott Maslan has shown a buying trading pattern, with $43.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Scott Maslan was on Sep 5, 2008, when they purchased $15.0K worth of GTF shares. This transaction involved 20,000 shares at $0.75 per share.
Andrew Scott Maslan currently owns 112,780 shares of CYTOMEDIX INC (GTF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Scott Maslan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Scott Maslan has 24 Form 4 filings on record as an insider at CYTOMEDIX INC.
Set alerts for Andrew Scott Maslan and 40,000+ other insiders.